85 related articles for article (PubMed ID: 21167448)
41. Clinical and molecular analysis of synchronous double lung cancers.
Arai J; Tsuchiya T; Oikawa M; Mochinaga K; Hayashi T; Yoshiura K; Tsukamoto K; Yamasaki N; Matsumoto K; Miyazaki T; Nagayasu T
Lung Cancer; 2012 Aug; 77(2):281-7. PubMed ID: 22560922
[TBL] [Abstract][Full Text] [Related]
42. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
43. A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109).
Hattori Y; Satouchi M; Shimada T; Urata Y; Yoneda T; Mori M; Nishimura T; Sunadome H; Kumagai T; Imamura F; Fujita S; Kaji R; Hata A; Tachihara M; Morita S; Negoro S
Lung Cancer; 2015 Feb; 87(2):136-40. PubMed ID: 25553650
[TBL] [Abstract][Full Text] [Related]
44. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
45. The South Region Cancer Registry: an evaluation of its exhaustiveness in a cohort of lung cancer patients.
Verdasca J; Costa FA; Ramos C; Murteira R; Miranda A
Thorac Cancer; 2019 Feb; 10(2):330-334. PubMed ID: 30485701
[TBL] [Abstract][Full Text] [Related]
46. [Intrahospital mortality during acute exacerbations of COPD. Study EABPCO-CPHG of the College of the Lung specialists of General hospitals (CPHG)].
Chavaillon JM; Lerousseau L; David P; Martin F; Lamour C; Beraud A; Sleiman C; Debieuvre D; Just N; Senechal F; Camuset J; Mornet M; Fesq G; Zureik M; Roche N; Blanchon F; Piquet J
Rev Mal Respir; 2010 Sep; 27(7):709-16. PubMed ID: 20863971
[TBL] [Abstract][Full Text] [Related]
47. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
Lee JS; Kim HR; Lee CY; Shin M; Shim HS
Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
[TBL] [Abstract][Full Text] [Related]
48. [Treatment and prognosis of advanced stage non-small-cell lung cancer].
Chermiti Ben Abdallah F; Ben Ali G; Sadok Boudaya M; Mlika M; Chtourou A; Taktak S; Ben Kheder A
Rev Mal Respir; 2014 Mar; 31(3):214-20. PubMed ID: 24680112
[TBL] [Abstract][Full Text] [Related]
49. Earlier onset and poor prognosis of lung cancer in imprisoned patients.
Carbonnaux M; Fossard G; Amzallag E; Piegay C; Perot E; Chossegros P; Souquet PJ; Couraud S
Oncology; 2013; 85(6):370-7. PubMed ID: 24335502
[TBL] [Abstract][Full Text] [Related]
50. Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation.
Fujita Y; Suda K; Kimura H; Matsumoto K; Arao T; Nagai T; Saijo N; Yatabe Y; Mitsudomi T; Nishio K
J Thorac Oncol; 2012 Nov; 7(11):1640-4. PubMed ID: 22899358
[TBL] [Abstract][Full Text] [Related]
51. High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer.
Stone E; Allen HA; Saghaie T; Abbott A; Daniel R; Mead RS; Kohonen-Corish M; Plit M; Morgan L
Intern Med J; 2014 Dec; 44(12a):1188-92. PubMed ID: 25228365
[TBL] [Abstract][Full Text] [Related]
52. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
53. Recent results of postoperative mortality for surgical resections in lung cancer.
Watanabe S; Asamura H; Suzuki K; Tsuchiya R
Ann Thorac Surg; 2004 Sep; 78(3):999-1002; discussion 1002-3. PubMed ID: 15337036
[TBL] [Abstract][Full Text] [Related]
54. Rapid detection of hotspot mutations in epidermal growth factor receptor by polymerase chain reaction facilitates the management of non-small cell lung cancer.
Hung KS; Lee CN; Liu HE
J Thorac Oncol; 2008 Oct; 3(10):1202-3. PubMed ID: 18827621
[No Abstract] [Full Text] [Related]
55. [Epidemiology and delays in the management of 355 patients with lung cancer].
Virally J; Choudat L; Chebbo M; Sartene R; Jagot JL; Elhadad A; Brassier D; Habib E; Chalmin B; Boiron C; Bienvenu L; Duperrin V; Mathieu M
Rev Mal Respir; 2006 Feb; 23(1 Pt 1):43-8. PubMed ID: 16604025
[TBL] [Abstract][Full Text] [Related]
56. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
57. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
[TBL] [Abstract][Full Text] [Related]
58. BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
Vavalà T; Follador A; Tiseo M; Galetta D; Morabito A; Di Maio M; Martelli O; Caffo O; Piovano PL; Cortinovis D; Zilembo N; Casartelli C; Banna GL; Ardizzoia A; Barzelloni ML; Bearz A; Genestreti G; Mucciarini C; Filipazzi V; Menis J; Rizzo E; Barbieri F; Rijavec E; Cecere F; Bria E; Spitaleri G; Rossi A; Novello S
Lung Cancer; 2016 May; 95():73-81. PubMed ID: 27040855
[TBL] [Abstract][Full Text] [Related]
59. [Overall long-term survival in lung cancer analyzed in 610 unselected patients].
Sánchez de Cos Escuín J; Disdier Vicente C; Corral Peñafiel J; Riesco Miranda JA; Sojo González MA; Masa Jiménez JF
Arch Bronconeumol; 2004 Jun; 40(6):268-74. PubMed ID: 15161593
[TBL] [Abstract][Full Text] [Related]
60. New aspects of the clinicopathology and genetic profile of metachronous multiple lung cancers.
Wu CT; Lin MW; Hsieh MS; Kuo SW; Chang YL
Ann Surg; 2014 May; 259(5):1018-24. PubMed ID: 24368645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
